BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $729,000 | +4.9% | 5,000 | -14.7% | 0.25% | +30.3% |
| Q1 2022 | $695,000 | -10.9% | 5,860 | +3.5% | 0.20% | -7.6% |
| Q4 2021 | $780,000 | +24.8% | 5,660 | +25.8% | 0.21% | +17.2% |
| Q3 2021 | $625,000 | +43.0% | 4,500 | 0.0% | 0.18% | +40.6% |
| Q2 2021 | $437,000 | +41.9% | 4,500 | 0.0% | 0.13% | +30.6% |
| Q1 2021 | $308,000 | -26.1% | 4,500 | -7.6% | 0.10% | -30.5% |
| Q4 2020 | $417,000 | +42.3% | 4,870 | +8.2% | 0.14% | +17.5% |
| Q3 2020 | $293,000 | +48.7% | 4,500 | +66.7% | 0.12% | -7.0% |
| Q2 2020 | $197,000 | +20.9% | 2,700 | -10.0% | 0.13% | +53.6% |
| Q4 2019 | $163,000 | +96.4% | 3,000 | +50.0% | 0.08% | +82.6% |
| Q3 2019 | $83,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |